Daria Alakhova (Filonova)
Daria Alakhova (Filonova)
Research scientific administrator, UNC Chapel Hill, NC
Verified email at
Cited by
Cited by
Endocytosis of nanomedicines
G Sahay, DY Alakhova, AV Kabanov
Journal of controlled release 145 (3), 182-195, 2010
Pluronics and MDR reversal: an update
DY Alakhova, AV Kabanov
Molecular pharmaceutics 11 (8), 2566-2578, 2014
Structure-property relationship in cytotoxicity and cell uptake of poly (2-oxazoline) amphiphiles
R Luxenhofer, G Sahay, A Schulz, D Alakhova, TK Bronich, R Jordan, ...
Journal of Controlled Release 153 (1), 73-82, 2011
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity
Z He, X Wan, A Schulz, H Bludau, MA Dobrovolskaia, ST Stern, ...
Biomaterials 101, 296-309, 2016
Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers
DY Alakhova, NY Rapoport, EV Batrakova, AA Timoshin, S Li, D Nicholls, ...
Journal of Controlled Release 142 (1), 89-100, 2010
A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer
Y Zhao, DY Alakhova, JO Kim, TK Bronich, AV Kabanov
Journal of controlled release 168 (1), 61-69, 2013
Can nanomedicines kill cancer stem cells?
Y Zhao, DY Alakhova, AV Kabanov
Advanced drug delivery reviews 65 (13-14), 1763-1783, 2013
Poly (2-oxazoline) based micelles with high capacity for 3rd generation taxoids: Preparation, in vitro and in vivo evaluation
Z He, A Schulz, X Wan, J Seitz, H Bludau, DY Alakhova, DB Darr, ...
Journal of controlled release 208, 67-75, 2015
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85
EV Batrakova, DL Kelly, S Li, Y Li, Z Yang, L Xiao, DY Alakhova, ...
Molecular pharmaceutics 3 (2), 113-123, 2006
Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia
DY Alakhova, Y Zhao, S Li, AV Kabanov
PloS one 8 (8), e72238, 2013
Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles
Y Zhao, DY Alakhova, X Zhao, V Band, EV Batrakova, AV Kabanov
Nanomedicine: Nanotechnology, Biology and Medicine 24, 102124, 2020
Fast path message transfer agent
B Taylor
US Patent 7,487,212, 2009
Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells
X Zhang, DY Alakhova, EV Batrakova, S Li, Z Yang, Y Li, AV Kabanov
Journal of Neuroimmune Pharmacology 4, 35-46, 2009
Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers
V Mahajan, Z Gaymalov, D Alakhova, R Gupta, IH Zucker, AV Kabanov
Biomaterials 75, 58-70, 2016
Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors
H Hu, A Petrosyan, NA Osna, T Liu, AA Olou, DY Alakhova, PK Singh, ...
Journal of Controlled Release 306, 149-164, 2019
Nanomedicine and nanotechnology are rapidly developing fields across the nation and worldwide.
DY Alakhova, AV Kabanov
Journal of controlled release: official journal of the Controlled Release …, 2015
Drug Delivery in Oncology. From Basic Research to Cancer Therapy. 3 Volumes. Edited by Felix Kratz, Peter Senter and Henning Steinhagen.
DY Alakhova, AY Kabanov
Angewandte Chemie International Edition 53 (14), 3547-3548, 2014
Endocytosis of nanomedicines
DY Alakhova, G Sahay, AV Kabanov
Journal of Controlled Release 145 (3), 182-195, 2010
Compositions and methods for the treatment of cancer
AV Kabanov, DY Alakhova, Y Zhao
US Patent 10,022,325, 2018
Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers
V Mahajan, Z Gaymalov, D Alakhova, R Gupta, IH Zucker, AV Kabanov
Data in brief 7, 1269-1282, 2016
The system can't perform the operation now. Try again later.
Articles 1–20